RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Berkeley Catalyst Fund
B

Berkeley Catalyst Fund (BCF) portfolio

Berkeley Catalyst Fund (BCF) has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $67M.
Latest deal: Frontier Medicines · Jun 25, 2019.
About this page

Its most recent investment on record is Frontier Medicines's $67M Series A round in June 2019, alongside DCVC Bio, Droia Ventures, MPM Capital and 2 others. By category, its portfolio leans toward Health and bio (2).

What Berkeley Catalyst Fund invests in

How Berkeley Catalyst Fund invests

StageDealsCapital in rounds
Series A 1 100%$67M

Berkeley Catalyst Fund portfolio companies

CompanyRound with Berkeley Catalyst FundTotal raisedLatest raise
FFrontier Medicines
Health and bio
 Series A · $67M$235.5MAug 28, 2025
Series B+
FFiltricine
Health and bio
 backerundisclosed—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Berkeley Catalyst Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Berkeley Catalyst Fund, which is a subset of its real portfolio. API: /api/v1/investors/berkeley-catalyst-fund (get a free API key). More: the most active VC firms and new venture capital funds.